GlassScriptPhysician profile
Donald Willis
NPI 1316940372
$3,371.93
in general payments reported to CMS, 2019-2025
17 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $541 · 2021: $186 · 2022: $529 · 2023: $1,327 · 2024: $456 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,824 · Travel and Lodging: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,824.36 |
| Travel and Lodging | $292.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,326.31 | 2019-2024 | Ams 700, Tactra |
| Teleflex LLC | $430.55 | 2023 | Urolift |
| Coloplast Corp | $239.73 | 2019-2023 | Porges Coloplast |
| Urogen Pharma, INC. | $203.26 | 2022 | |
| Medtronic, INC. | $192.38 | 2023 | Signia |
| Silk Road Medical, INC. | $174.89 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Bolton Medical INC | $144.90 | 2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Gelweave |
| Urovant Sciences INC | $109.12 | 2022 | |
| Inspire Medical Systems, INC. | $106.22 | 2025 | Inspire |
| Intuitive Surgical, INC. | $88.59 | 2023 | Da Vinci Surgical System |
| Imperative Care, INC | $81.73 | 2025 | Symphony Catheter |
| Axonics, INC. | $80.16 | 2021 | |
| Progenics Pharmaceuticals, INC. | $64.95 | 2023 | Pylarify |
| Merck Sharp & Dohme LLC | $51.59 | 2019 | |
| Foundation Fusion Solutions, LLC | $47.06 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $18.40 | 2019 | |
| Astellas Pharma US INC | $12.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Willis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.